journal
https://read.qxmd.com/read/37385711/pediatric-urology-2023
#1
EDITORIAL
Carlos R Estrada
No abstract text is available yet for this article.
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385710/july-1-1982-the-birth-of-the-modern-urology-service-at-boston-children-s-hospital
#2
EDITORIAL
Kevin R Loughlin
No abstract text is available yet for this article.
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385709/diagnosis-classification-and-contemporary-management-of-undescended-testicles
#3
REVIEW
Emily R Chedrawe, Daniel T Keefe, Rodrigo L P Romao
This article provides a comprehensive review regarding undescended testicles and other related conditions. We have included background information summarizing variable clinical presentations, epidemiology, and the implications of undescended testis (UDT) on fertility and malignancy risk. This article has an emphasis on the approach to diagnosis and surgical management for the UDT. The purpose of this review is to provide readers with useful clinical tools for assessing and treating patients with cryptorchidism...
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385708/pediatric-stone-disease-current-trends-and-future-directions
#4
REVIEW
Ching Man Carmen Tong, Jonathan S Ellison, Gregory E Tasian
Pediatric nephrolithiasis is less common in children than in adults but the incidence has been rising rapidly, and it is now a public health and economic burden in the United States. There are challenges unique to children that should be taken into consideration when evaluating and managing pediatric stone disease. In this review, we present the current research on risk factors, emerging new technologies for treatment of stones and recent investigations on prevention of stones in this population.
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385707/wilms-tumor
#5
REVIEW
Amanda F Saltzman, Nicholas G Cost, Rodrigo L P Romao
Wilms tumor (WT), or nephroblastoma, is the most common primary malignant renal tumor of childhood. It is an embryonal tumor that develops from remnants of immature kidney. There are approximately 500 new WT cases diagnosed in the United States every year. Advances in multimodal therapy including surgery, chemotherapy, and radiation therapy given according to risk stratification have allowed most patients to achieve survival rates in excess of 90%.
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385706/what-adults-teach-urologists-about-hypospadias
#6
REVIEW
Warren Snodgrass, Nicol Bush
Knowledge regarding the impact of hypospadias in adults helps inform decision-making in childhood and potentially answers the question if repair should be delayed until during or after puberty. Earlier studies suggested that men with uncorrected hypospadias were either not aware of their condition or not bothered by it. Recent reports disagree and find that those with hypospadias are concerned by their difference and experience more penile dysfunction that men without this birth defect.
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385705/differences-of-sex-development-current-issues-and-controversies
#7
REVIEW
Emilie K Johnson, Jax Whitehead, Earl Y Cheng
Differences of sex development (DSD) encompass a broad range of conditions in which the development of chromosomal, gonadal, or anatomic sex is not typically male or female. Terms used to describe DSD are controversial, and continuously evolving. An individualized, multidisciplinary approach is key to both the diagnosis and management of DSD. Recent advances in DSD care include expanded genetic testing options, a more nuanced approach to gonadal management, and an emphasis on shared decision-making, particularly related to external genital surgical procedures...
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385704/neurogenic-lower-urinary-tract-dysfunction
#8
REVIEW
John S Wiener, Rajeev Chaudhry
Neurogenic lower urinary tract dysfunction (NLUTD) remains a formidable challenge to pediatric urologists to achieve the goals of renal preservation and the reduction of urinary tract infections as well as the attainment of continence and independence as children grow toward adulthood. Tremendous progress has occurred over the past 50 years which have witnessed an evolution in focus from mere survival to optimal quality of life. This review presents four separate guidelines for the medical and surgical care of pediatric NLUTD, most commonly related to spina bifida, to highlight the change in approach from expectant to more proactive management...
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385703/exstrophy-epispadias-complex
#9
REVIEW
Ted Lee, Joseph Borer
Exstrophy-epispadias complex encompasses a spectrum of disorders with lower abdominal midline malformations, including epispadias, bladder exstrophy, and cloacal exstrophy, also known as Omphalocele-Exstrophy-Imperforate Anus-Spinal Anomalies Complex. In this review, the authors discuss the epidemiology, embryologic cause, prenatal findings, phenotypic characteristics, and management strategies of these 3 conditions. The primary focus is to summarize outcomes pertaining to each condition.
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385702/vesicoureteral-reflux-current-care-trends-and-future-possibilities
#10
REVIEW
Eric M Bortnick, Caleb P Nelson
Although investigations over the past 2 decades have improved our understanding of the natural history of vesicoureteral reflux (VUR) and helped identify those at higher risk of both VUR itself as well as its potential severe sequelae, debate exists regarding key aspects of care, including when to perform diagnostic imaging and which patients benefit from continuous antibiotic prophylaxis. Artificial intelligence and machine learning have the potential to distill large volumes of granular data into practical tools that clinicians can use to guide diagnosis and management decisions...
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385701/embryology-treatment-and-outcomes-of-ureteroceles-in-children
#11
REVIEW
Hans G Pohl
A ureterocele is a congenital cystic dilatation of the intravesical ureter that may affect either a single system kidney or the upper pole of a duplex system. The position of ureteral orifice correlates with function of associated renal moiety. Ureteroceles associated with good renal function and prompt drainage or ureteroceles associated with no renal function can be managed nonoperatively. Endoscopic puncture of ureteroceles addresses most cases; iatrogenic reflux may rarely require secondary surgery. Robot-assisted laparoscopic upper pole nephroureterectomy and ureteroureterostomy procedures are rarely associated with complications...
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385700/ureteropelvic-junction-obstruction-hydronephrosis
#12
REVIEW
Peter Y Cai, Richard S Lee
Congenital hydronephrosis can be classified and managed based on the Urinary Tract Dilation consensus scoring system. Ureteropelvic junction obstruction is one of the most common causes of hydronephrosis in the pediatric population. Although most cases can be managed conservatively with follow-up and serial imaging, some patients need surgical repair because of renal function deterioration, infections, or symptoms. Additional research to create predictive algorithms or develop noninvasive biomarkers for renal deterioration is necessary to better identify surgical candidates...
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/37385699/prenatal-diagnoses-and-intervention
#13
REVIEW
Michael P Kurtz
Fetal upper tract urinary system dilation is one of the most common findings on prenatal ultrasonography. Rarely, this may represent fetal lower urinary tract obstruction (LUTO), of which posterior urethral valves are the predominant etiology. LUTO is the most dire fetal urologic diagnosis, as it affects not only the baby's management after birth but sometimes the course of the pregnancy itself. A variety of treatment options are available prenatally; these include observation, vesicoamniotic shunt placement, amnioinfusion, and attempts at direct treatment of the valves themselves...
August 2023: Urologic Clinics of North America
https://read.qxmd.com/read/36948678/the-progession-landscape-of-diagnostic-and-treatment-options-for-kidney-cancer
#14
EDITORIAL
Steven L Chang, Michael L Blute
No abstract text is available yet for this article.
May 2023: Urologic Clinics of North America
https://read.qxmd.com/read/36948677/when-you-hear-hoofbeats-sometimes-think-of-zebras
#15
EDITORIAL
Kevin R Loughlin
No abstract text is available yet for this article.
May 2023: Urologic Clinics of North America
https://read.qxmd.com/read/36948676/the-changing-landscape-of-immunotherapy-for-advanced-renal-cancer
#16
REVIEW
Soki Kashima, David A Braun
The management of advanced renal cell carcinoma has advanced tremendously over the past decade, but most patients still do not receive durable clinical benefit from current therapies. Renal cellcarcinoma is an immunogenic tumor, historically with conventional cytokine therapies, such as interleukin-2 and interferon-α, and contemporarily with the introduction of immune checkpoint inhibitors. Now the central therapeutic strategy in renal cell carcinoma is combination therapies including immunecheckpoint inhibitors...
May 2023: Urologic Clinics of North America
https://read.qxmd.com/read/36948675/radiation-therapy-in-the-treatment-of-localized-and-advanced-renal-cancer
#17
REVIEW
Kendrick Yim, Jonathan E Leeman
Renal cell carcinoma (RCC) has historically been considered resistant to radiotherapy. However, advances in the field of radiation oncology have led to safe delivery of higher radiation doses through the use of stereotactic body radiotherapy (SBRT) that have shown significant activity against RCC. SBRT has now been shown to be a highly effective modality for management of localized RCC for nonsurgical candidates. Increasing evidence also points to a role for SBRT in the management of oligometastatic RCC as a means for not only providing palliation but prolonging time to progression and potentially improving survival...
May 2023: Urologic Clinics of North America
https://read.qxmd.com/read/36948674/integrating-surgery-in-the-multidisciplinary-care-of-advanced-renal-cell-carcinoma
#18
REVIEW
Shagnik Ray, Shawn Dason, Eric A Singer
The role of surgery for patients with locally advanced and metastatic renal cell carcinoma (RCC) is not precisely defined in our contemporary era of systemic therapies. Research in this field is focused on the role of regional lymphadenectomy, along with indications and timing of cytoreductive nephrectomy and metastasectomy. As our understanding of the molecular and immunological basis of RCC continues to develop along with the advent of novel systemic therapies, prospective clinical trials will be critical in defining how surgery should be integrated into the treatment paradigm of advanced RCC...
May 2023: Urologic Clinics of North America
https://read.qxmd.com/read/36948673/the-great-masquerader-s-new-wardrobe-in-the-modern-era-the-paraneoplastic-manifestations-of-renal-cancer
#19
REVIEW
Kevin R Loughlin
Paraneoplastic syndromes can occur in 8% to 20% of individuals with malignancies. They can occur in a variety of cancers that include breast, gastric, leukemia, lung, ovarian, pancreatic, prostate, testicular, as well as kidney. The classic presentation of the triad of mass, hematuria, and flank pain occurs in less than 15% of patients with renal cancer. Because of the protean presentations of renal cell cancer, it has been referred to as the internist's tumor or the great masquerader. This article will provide a review of the causes of these symptoms...
May 2023: Urologic Clinics of North America
https://read.qxmd.com/read/36948672/the-promise-of-neoadjuvant-and-adjuvant-therapies-for-renal-cancer
#20
REVIEW
Jeffrey J Leow, Shagnik Ray, Shawn Dason, Eric A Singer, Steven L Chang
Because metachronous metastatic disease will develop in 20% to 40% of patients with presumed localized renal cell carcinoma (RCC) treated surgically, research is focused on neoadjuvant and adjuvant systemic therapy, to improve disease-free and overall survival. Neoadjuvant therapies trialed include anti-vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) agents, or combination therapies (immunotherapy with TKI), and aim to improve resectability of locoregional RCC. Adjuvant therapies trialed include cytokines, anti-VEGF TKI agents, or immunotherapy...
May 2023: Urologic Clinics of North America
journal
journal
25018
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.